ELDN
NASDAQ · Biotechnology
Eledon Pharmaceuticals Inc
$2.19
+0.22 (+11.17%)
Analyst Consensus
Strong Buy
13
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+452.1% upside
Low Target
$9.42
Average Target
$12.09
High Target
$15.53
Current Price
$2.19
Current
$2.19
$2.19
Target
$12.09
$12.09
$9.42
$12.09 avg
$15.53
Scenario Analysis
Bear Case
$9.42
330.1%
Low target
Base Case
$12.09
+452.1%
Avg target
Bull Case
$15.53
+609.1%
High target
Risk/Reward
1.8x
Balanced
Price in Context
52-Week High
$15.17
-85.6% from high
52-Week Low
$8.95
+-75.5% from low
Target vs 52W High
$12.09
-20.3% vs high
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Buy | 37 | 68% | $257.58 | +15.3% |
| AMGN | Hold | 41 | 54% | $190.87 | -50.3% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +137.8% |
| VRTX | Strong Buy | 39 | 77% | $438.34 | -8.3% |
| REGN | Strong Buy | 36 | 75% | $76.80 | -90.2% |
| ALNY | Strong Buy | 36 | 75% | $102.31 | -68.8% |
| INSM | Strong Buy | 27 | 93% | $143.40 | -4.3% |
| BIIB | Hold | 42 | 48% | $91.45 | -54.5% |